Safety and tolerability of diuretics withdrawal in patients with heart failure with reduced ejection fraction. REDICAE trial

18 May 2025 (13:45 - 13:55)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Jesus Alberto Torres Zamudio

Reina Sofia University Hospital, Cordoba (Spain)

5 More presentations in this session

Presentation thumbnail

Oral iron supplementation with ferric maltol improves iron deficiency anaemia in patients with chronic heart failure

Professor T. Kempf (Hannover, DE)

Presentation thumbnail

Gene therapy for heart failure with preserved ejection fraction

Doctor M. Fudim (Durham, US)

Presentation thumbnail

NAN-CS101: A first-in-human Phase 1 open-label dose-escalation study of AB-1002 gene therapy for the treatment of NYHA class III heart failure

Doctor R. Hajjar (Boston, US)

Presentation thumbnail

Finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomized placebo-controlled mechanistic trial (FIVE-STAR)

Professor A. Tanaka (Saga, JP)

Presentation thumbnail

Cardio-microcurrent device for chronic heart failure: results from the C-MIC II randomized controlled trial

Professor S. Anker (Berlin, DE)

Access the full session

Session thumbnail

Late-breaking clinical trials in chronic heart failure

The Event

Event poster

Heart Failure 2025

18 May 2025 13:45 CET

You may be interested in

Congress Session

Late breaking clinical trials: medical therapy

Congress Session

Clinical trial updates on heart failure

Congress Presentation

Diuretic treatment in acute heart failure with volume overload guided by serial spot urine sodium assessment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources